A systematic review of eight randomized trials finds MDMA-AT reduced psychopathology more than controls, but with high variability and poor harm reporting.
Evidence grade A · meta-analysis / systematic review. Here’s an honest read of what this study does — and doesn’t — show.
Original art — ShroomWire
What the study found
Researchers found MDMA-assisted therapy was associated with a moderate-to-large incremental reduction in psychopathology compared to control conditions (effect size g = 1.03), with stronger effects against inert placebos than active controls. The effect was largest for trauma-related symptoms (g = 1.46) and smaller and non-significant for depression (g = 0.51). Only 23% of publications met high-quality standards for reporting harms.
Why it matters
The findings suggest researchers are exploring MDMA-AT as a potentially transdiagnostic intervention, but the gap between promising effect sizes and poor harm reporting transparency underscores why regulators and clinicians have called for larger, more rigorously conducted trials before drawing firm conclusions.
This article is for informational and educational purposes only. It is not
medical advice, mental health advice, diagnosis, treatment guidance, or a
recommendation to use any substance, supplement, therapy, or protocol.
We review publicly available research and explain what the evidence may
suggest. Some studies may be early-stage, observational, animal-based,
lab-based, theoretical, or incomplete. Always consult a qualified
professional before making health-related decisions.
If you or someone you know is struggling, you are not alone. In the US, call or text 988 (Suicide & Crisis Lifeline). Elsewhere, contact your local emergency or crisis service.
Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.
Frequently asked questions
Does MDMA-assisted therapy cure PTSD or trauma?
The study does not show that MDMA-AT cures PTSD or trauma. The meta-analysis found it was associated with a moderate-to-large reduction in trauma-related symptoms compared to controls, but this cannot establish causation due to possible unblinding, expectancy effects, and other limitations.
Is MDMA-assisted therapy safe based on current research?
The safety profile remains unclear. Only 23% of the studies reviewed met high-quality standards for reporting harms, so researchers and regulators have called for larger, more rigorously conducted trials before drawing firm conclusions about safety.
Does MDMA-assisted therapy work for depression?
The evidence for depression was smaller and not statistically significant in this review (effect size g = 0.51). The strongest effects were seen for trauma-related symptoms, not depression.
Why do some experts say more research is needed on MDMA-AT?
The total sample was small (295 participants), results varied widely between studies, and harm reporting was poor. These limitations mean the findings may not generalize, and larger, more rigorous trials are needed to confirm what the current evidence may suggest.
Psilocybin depression research suggests standard-dose psilocybin may be associated with reduced depressive symptoms, but more studies are needed to confirm…
A single 15-minute trip can outperform methadone on paper. When researchers pooled every published trial of N,N-dimethyltryptamine (DMT) against alcohol, opioids, cocaine, or nicotine, the average…
Float tanks can trigger “aquahenosis,” an altered state that mirrors psilocybin trips—no drugs required. Here’s what 75 anxious volunteers felt inside the dark, silent water.
DMT therapy was associated with large reductions in cocaine and opioid use, but may suggest a need for further research to confirm its efficacy and safety
